Federal Register / Vol. 76, No. 166 / Friday, August 26, 2011 / Notices 53477 

transport, storage, set-up, safety, or 

timely arrival of any personal 

belongings or items used for 

presentation or to support a 

presentation. 

Note: Individuals who are not registered in 

advance will not be permitted to enter the 

building and will be unable to attend the 

meeting. The public may not enter the 

building earlier than 45 minutes prior to the 

convening of the meeting. All visitors must 

be escorted in areas other than the lower and 

first floor levels in the Central Building. 

Authority: 5 U.S.C. App. 2, section 10(a). 

(Catalog of Federal Domestic Assistance 

Program No. 93.773, Medicare—Hospital 

Insurance; and Program No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program) 

Dated: August 17, 2011. 

Patrick Conway, 

CMS Chief Medical Officer and Director, 

Office of Clinical Standards and Quality, 

Centers for Medicare & Medicaid Services. 

[FR Doc. 2011–21706 Filed 8–25–11; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3251–N2] 

Medicare Program; Meeting of the 

Medicare Evidence Development and 

Coverage Advisory Committee; 

Cancellation of the September 21, 2011 

Meeting 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces the 

cancellation of the September 21, 2011 

public meeting of the Medicare 

Evidence Development & Coverage 

Advisory Committee (MEDCAC) 

(‘‘Committee’’) that was published in 

the July 22, 2011 Federal Register (76 

FR 44011 through 44012). This notice 

also announces a public meeting on 

Wednesday, March 21, 2012. The 

Committee generally provides advice 

and recommendations concerning the 

adequacy of scientific evidence needed 

to determine whether certain medical 

items and services can be covered under 

the Medicare statute. This meeting will 

focus on the currently available 

evidence regarding antivascular 

endothelial growth factor (anti-VEGF) 

treatment of diabetic macular edema 

(DME). This meeting is open to the 

public in accordance with the Federal 

Advisory Committee Act (5 U.S.C. App. 

2, section 10(a)). 

DATES: Meeting Date: The public 

meeting will be held on Wednesday, 

March 21, 2012 from 7:30 a.m. until 

4:30 p.m., Daylight Saving Time (DST). 

Deadline for Submission of Written 

Comments: Written comments must be 

received at the address specified in the 

ADDRESSES section of this notice by 

5 p.m. Eastern Standard Time (EST), 

Tuesday, February 21, 2012. Once 

submitted, all comments are final. 

Deadlines for Speaker Registration 

and Presentation Materials: The 

deadline to register to be a speaker and 

to submit PowerPoint presentation 

materials and writings that will be used 

in support of an oral presentation, is 

5 p.m., EST on Tuesday, February 21, 

2012. Speakers may register by phone or 

via e-mail by contacting the person 

listed in the FOR FURTHER INFORMATION

CONTACT section of this notice. 

Presentation materials must be received 

at the address specified in the 

ADDRESSES section of this notice. 

Deadline for All Other Attendees 

Registration: Individuals may register 

online at http://www.cms.gov/apps/ 

events/upcomingevents.

asp?strOrderBy=1&type=3 or by phone 

by contacting the person listed in the 

FOR FURTHER INFORMATION CONTACT

section of this notice by 5 p.m. DST, 

Friday, March 16, 2012. 

We will be broadcasting the meeting 

live via Webcast at http://www.cms.gov/ 

live/. 

Deadline for Submitting a Request for 

Special Accommodations: Persons 

attending the meeting who are hearing 

or visually impaired, or have a 

condition that requires special 

assistance or accommodations, are 

asked to contact the Executive Secretary 

as specified in the FOR FURTHER

INFORMATION CONTACT section of this 

notice no later than 5 p.m., EST Friday, 

March 2, 2012. 

ADDRESSES: Meeting Location: The 

meeting will be held in the main 

auditorium of the Centers for Medicare 

& Medicaid Services, 7500 Security 

Boulevard, Baltimore, MD 21244. 

Submission of Presentations and 

Comments: Presentation materials and 

written comments that will be presented 

at the meeting must be submitted via email to MedCACpresentations@cms. 

hhs.gov or by regular mail to the contact 

listed in the FOR FURTHER INFORMATION

CONTACT section of this notice by the 

date specified in the DATES section of 

this notice. 

FOR FURTHER INFORMATION CONTACT: 

Maria Ellis, Executive Secretary for 

MEDCAC, Centers for Medicare & 

Medicaid Services, Office of Clinical 

Standards and Quality, Coverage and 

Analysis Group, S3–02–01, 7500 

Security Boulevard, Baltimore, MD 

21244 or contact Ms. Ellis by phone 

(410–786–0309) or via e-mail at 

Maria.Ellis@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

MEDCAC, formerly known as the 

Medicare Coverage Advisory Committee 

(MCAC), provides advice and 

recommendations to CMS regarding 

clinical issues. (For more information 

on MCAC, see the December 14, 1998 

Federal Register (63 FR 68780).) This 

notice announces the March 21, 2012, 

public meeting of the Committee. 

During this meeting, the Committee will 

discuss the currently available evidence 

regarding antivascular endothelial 

growth factor (anti-VEGF) treatment of 

diabetic macular edema (DME). 

Background information about this 

topic, including panel materials, is 

available at http://www.cms.gov/ 

medicare-coverage-database/indexes/

medcac-meetings-index.aspx?bc=

BAAAAAAAAAAA&. CMS will no 

longer be providing paper copies of the 

handouts for the meeting. Electronic 

copies of all the meeting materials will 

be on the CMS Web site no later than 

2 business days before the meeting. We 

encourage the participation of 

appropriate organizations with expertise 

in the treatment of diabetic retinopathy 

(DR) and DME. 

II. Meeting Format 

This meeting is open to the public. 

The agenda for the day of the meeting 

offers two opportunities for the public 

to participate as either a registered 

scheduled speaker or an unscheduled 

speaker. The Committee will hear oral 

presentations from the registered 

scheduled speakers for approximately 

45 minutes. Time allotted for each 

presentation may be limited. If the 

number of registrants requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

open public hearing session, CMS may 

conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by February 23, 2012. 

Your comments should focus on issues 

specific to the list of topics that we have 

proposed to the Committee. The list of 

research topics to be discussed at the 

meeting will be available on the 

following Web site prior to the meeting: 

http://www.cms.gov/medicare-coveragedatabase/indexes/medcac-meetingsindex.aspx?bc=BAAAAAAAAAAA&. 

We require that you declare at the 


emcdonald on DSK2BSOYB1PROD with NOTICES
53478 Federal Register / Vol. 76, No. 166 / Friday, August 26, 2011 / Notices 

meeting whether you have any financial 

involvement with manufacturers (or 

their competitors) of any items or 

services being discussed. 

The Committee will deliberate openly 

on the topics under consideration. 

Interested persons may observe the 

deliberations, but the Committee will 

not hear further comments during this 

time except at the request of the 

chairperson. The Committee will also 

allow a 15-minute open public session 

for any unscheduled speaker to address 

issues specific to the topics under 

consideration. At the conclusion of the 

day, the members will vote and the 

Committee will make its 

recommendation(s) to CMS. 

III. Registration Instructions 

CMS’ Coverage and Analysis Group is 

coordinating meeting registration. While 

there is no registration fee, individuals 

must register to attend. You may register 

online at http://www.cms.gov/apps/ 

events/upcomingevents.

asp?strOrderBy=1&type=3 or by phone 

by contacting the person listed in the 

FOR FURTHER INFORMATION CONTACT

section of this notice by the deadline 

listed in the DATES section of this notice. 

Please provide your full name (as it 

appears on your state-issued driver’s 

license), address, organization, 

telephone, fax number(s), and e-mail 

address. You will receive a registration 

confirmation with instructions for your 

arrival at the CMS complex or you will 

be notified the seating capacity has been 

reached. 

IV. Security, Building, and Parking 

Guidelines 

This meeting will be held in a Federal 

government building; therefore, Federal 

security measures are applicable. We 

recommend that confirmed registrants 

arrive reasonably early, but no earlier 

than 45 minutes prior to the start of the 

meeting, to allow additional time to 

clear security. Security measures 

include the following: 

• Presentation of government-issued 

photographic identification to the 

Federal Protective Service or Guard 

Service personnel. 

• Inspection of vehicle’s interior and 

exterior (this includes engine and trunk 

inspection) at the entrance to the 

grounds. Parking permits and 

instructions will be issued after the 

vehicle inspection. 

• Inspection, via metal detector or 

other applicable means of all persons 

brought entering the building. We note 

that all items brought into CMS, 

whether personal or for the purpose of 

presentation or to support a 

presentation, are subject to inspection. 

We cannot assume responsibility for 

coordinating the receipt, transfer, 

transport, storage, set-up, safety, or 

timely arrival of any personal 

belongings or items used for 

presentation or to support a 

presentation. 

Note: Individuals who are not registered in 

advance will not be permitted to enter the 

building and will be unable to attend the 

meeting. The public may not enter the 

building earlier than 45 minutes prior to the 

convening of the meeting. All visitors must 

be escorted in areas other than the lower and 

first floor levels in the Central Building. 

Authority: 5 U.S.C. App. 2, section 10(a). 

(Catalog of Federal Domestic Assistance 

Program No. 93.773, Medicare—Hospital 

Insurance; and Program No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program) 

Dated: August 17, 2011. 

Patrick Conway, 

CMS Chief Medical Officer and Director, 

Office of Clinical Standards and Quality 

Centers for Medicare & Medicaid Services. 

[FR Doc. 2011–21708 Filed 8–25–11; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0528] 

Food Safety Modernization Act 

Domestic and Foreign Facility 

Reinspections, Recall, and Importer 

Reinspection User Fee Rates for Fiscal 

Year 2012; Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; correction. 

SUMMARY: The Food and Drug 

Administration (FDA) is correcting a 

notice that appeared in the Federal 

Register of August 1, 2011 (76 FR 

45820). The document announced the 

fiscal year 2012 fee rates for certain 

domestic and foreign facility 

reinspections, failure to comply with a 

recall order, and importer reinspections 

that are mandated in the FDA Food 

Safety Modernization Act (FSMA). The 

document was published with two 

typographical errors. This document 

corrects those errors. 

FOR FURTHER INFORMATION CONTACT: 

Amy Waltrip, 12420 Parklawn Dr., Rm. 

2012, Rockville, MD 20857, 301–796– 

8811, e-mail: Amy.Waltrip@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In FR Doc. 

FDA–2011–19331, appearing on page 

45820 in the Federal Register of 

Monday, August 1, 2011, the following 

corrections are made: 

1. On page 45822, in the second 

column, in the first line, ‘‘$335’’ is 

corrected to read ‘‘$325’’. 

2. On page 45822, in the second 

column, in ‘‘Table 3—FSMA Fee 

Schedule for FY 2012,’’ ‘‘$335’’ is 

corrected to read ‘‘$325’’. 

Dated: August 19, 2011. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2011–21895 Filed 8–25–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection: 

Comment Request 

In compliance with the requirement 

for opportunity for public comment on 

proposed data collection projects 

(section 3506(c)(2)(A) of Title 44, United 

States Code, as amended by the 

Paperwork Reduction Act of 1995, Pub. 

L. 104–13), the Health Resources and 

Services Administration (HRSA) 

publishes periodic summaries of 

proposed projects being developed for 

submission to the Office of Management 

and Budget (OMB) under the Paperwork 

Reduction Act of 1995. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and draft instruments, e-mail 

paperwork@hrsa.gov or call the HRSA 

Reports Clearance Officer at (301) 443– 

1129. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the Agency; (b) the 

accuracy of the Agency’s estimate of the 

burden of the proposed collection of 

information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Proposed Project: National Health 

Service Corps Site Survey (OMB No. 

0915–0232)—Revision 

The Health Resources and Services 

Administration (HRSA), Bureau of 

Clinician Recruitment and Service 

(BCRS) places National Health Service 

Corps (NHSC) health care professionals 

at sites that provide services to 

underserved and vulnerable 

populations. The NHSC Site Survey 


emcdonald on DSK2BSOYB1PROD with NOTICES